Bupropion Hydrochloride Tablet, Film Coated, Extended Release
Product Images NDC 43598-753

8 FDA label images from Dr. Reddy�s Laboratories Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Bupropion Hydrochloride (NDC 43598-753). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Dr. Reddy�s Laboratories Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Bupropion Hydrochloride Sr 1)

Chemical Structure (Bupropion Hydrochloride Sr 1)
Chemical structure diagram of bupropion hydrochloride, showing the molecular arrangement including a chlorophenyl group and other functional groups labeled with standard chemical notation.*
FDA Label Image

Bupropion-label1 (Bupropion Label1)

Bupropion-label1 (Bupropion Label1)
Label for Bupropion Hydrochloride SR Extended-Release Tablets, USP (SR) 100 mg by Dr. Reddy's Laboratories Inc. The label indicates a twice-a-day dosing after initial titration, contains 60 film-coated extended-release tablets for oral use. It includes a warning against use with Zyban or other medicines containing bupropion hydrochloride and states it is Rx only.*
FDA Label Image

Bupropion-label2 (Bupropion Label2)

Bupropion-label2 (Bupropion Label2)
The label is for Bupropion Hydrochloride SR Extended-Release Tablets in 100 mg strength by Dr. Reddy's Laboratories Inc. It specifies a twice-a-day dosing after initial titration, with 100 tablets in the package. The label includes pharmacist dispensing instructions, a warning against use with Zyban or other bupropion-containing medicines, storage conditions, manufacturing details, and an NDC number 43598-751-01.*
FDA Label Image

Bupropion-label3 (Bupropion Label3)

Bupropion-label3 (Bupropion Label3)
Label for Bupropion Hydrochloride SR 100 mg Extended-Release Tablets, USP (SR) by Dr. Reddy's Laboratories Inc., showing a 500-tablet prescription package. The label highlights dispensing instructions, a warning against combination with ZYBAN or similar medicines, and a barcode. It specifies the medication is for oral use and prescription only.*
FDA Label Image

Bupropion-label4 (Bupropion Label4)

Bupropion-label4 (Bupropion Label4)
Label for Bupropion Hydrochloride Extended-Release Tablets USP (SR) 150 mg by Dr. Reddy's Laboratories Inc. It indicates the dosage form as film-coated, extended-release tablets, available in a 60-tablet bottle. The label includes warnings against combining with Zyban and mandates dispensing an accompanying medication guide.*
FDA Label Image

Bupropion-label5 (Bupropion Label5)

Bupropion-label5 (Bupropion Label5)
Label for Bupropion Hydrochloride SR 150 mg extended-release tablets, USP, film coated, oral dosage form. The label indicates a 100-tablet bottle with a warning not to use in combination with Zyban or other medicines containing bupropion hydrochloride. Manufactured by Dr. Reddy's Laboratories Inc., the label includes directions for pharmacists to dispense accompanying medication guide to each patient.*
FDA Label Image

Bupropion-label6 (Bupropion Label6)

Bupropion-label6 (Bupropion Label6)
Label for Bupropion Hydrochloride SR Extended-Release Tablets, USP (SR) 150 mg by Dr. Reddy's Laboratories Inc. The label indicates the product is for oral use and supplied as film-coated extended-release tablets. It contains warnings about drug combinations and includes instructions for pharmacists to dispense an accompanying medication guide. The package size is 500 tablets, and the label features the NDC 43598-752-05.*
FDA Label Image

Bupropion-label7 (Bupropion Label7)

Bupropion-label7 (Bupropion Label7)
Label for Bupropion Hydrochloride SR Extended-Release Tablets, USP, 200 mg strength, film-coated, for oral use. The package contains 60 tablets and is labeled for twice-a-day use after initial titration. It includes a warning about not using the drug with Zyban or other medicines containing bupropion hydrochloride. The labeler is Dr. Reddy's Laboratories Inc., and the label provides dispensing instructions for pharmacists and regulatory information including the NDC 43598-753-60.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.